chronic 相關
廣告
搜尋結果
The U.S. Government Plans To Reclassify Marijuana From A Schedule I To Schedule III Drug. Here ...
Forbes· 4 日前The DEA is planning to reclassify marijuana from a Schedule I to a Schedule III controlled ...
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment
Reuters· 1 日前Indian pharmaceutical company Mankind Pharma posted a more than 65% rise in its fourth-quarter ...
Women, Want To Level Up Your Career? Ditch The Superhero Narrative
Forbes· 17 小時前This societal expectation, while seemingly empowering, is increasingly proving detrimental. The ...
Upturn in Egypt's economic fortunes tempered by caution on reform
Reuters· 8 小時前Egypt appears on track to break with past practice and let its currency float in line with ...
US unveils proposal to ease restrictions on marijuana
Reuters· 5 小時前Schedule one drugs, such as heroin, are considered highly addictive with no medical benefits, ...
Hong Kong to launch first breastmilk bank next year to aid 600 infants annually
South China Morning Post· 11 小時前The authority said the bank would accept applications from eligible mothers in the fourth ...
Shares of this gene editing company are due to surge more than 45%, Citi says
CNBC· 8 小時前After a period of steady underperformance, investors should pick up shares of biotech Prime ...
Dietitian startup Fay has been booming from Ozempic patients and emerges from stealth with $25M ...
TechCrunch· 1 日前For years, Sammy Faycurry has been hearing from his dietician mom and sister about how poorly ...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 17 小時前Earlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR ...
Medicare Advantage: Triple Threat Mounts for Insurers
The Wall Street Journal· 6 日前Medicare Advantage plans are health plans offered by private insurance companies in place of ...
chronic 相關
廣告